|
103
|
362
|
5hbeA |
Cdk8-cycc in complex with 8-[3-chloro-5-(1-methyl-2,2-dioxo-2, 3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-pyridin- 4-yl]-1-oxa-3,8-diaza-spiro[4.5]decan-2-one |
|
73
|
219
|
5hglA |
Hexameric hiv-1 ca, open conformation |
|
44
|
129
|
5hnlA |
In-house x-ray single crystal diffraction from protein microcrystals via magnetically oriented microcrystal arrays in gels |
|
232
|
581
|
5hozA |
Crystal structure of equine serum albumin (esa) at ph 9.0 |
|
31
|
78
|
5h9cA |
Crystal structure of the aslv fusion protein core |
|
86
|
284
|
5hg9A |
Egfr (l858r, t790m, v948r) in complex with 1-[(3r,4r)-3-[({2-[(1-methyl-1h-pyrazol-4-yl)amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-(trifluoromethyl)pyrrolidin-1-yl]prop-2-en-1-one |
|
58
|
146
|
5hy8B |
Glycation restrains allosteric transition in hemoglobin: the molecular basis of oxidative stress under hyperglycemic conditions in diabetes |
|
36
|
89
|
5hlvA |
Crystal structure of calcium and zinc-bound human s100a8 in space group p212121 |
|
88
|
294
|
5i9uA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase |
|
112
|
259
|
5b1bC |
Bovine heart cytochrome c oxidase in the fully reduced state at 1.6 angstrom resolution |
|
46
|
132
|
4zdsA |
Crystal structure of core dna binding domain of arabidopsis thaliana transcription factor ethylene-insensitive 3 |
|
94
|
267
|
5idnB |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(3-methyl-1h-pyrazolo[3,4-b]pyridin-5-yl)-methanone |
|
25
|
79
|
5b1bH |
Bovine heart cytochrome c oxidase in the fully reduced state at 1.6 angstrom resolution |
|
265
|
948
|
5g2nA |
X-ray structure of pi3kinase gamma in complex with copanlisib |
|
26
|
95
|
5hv8A |
Solution structure of an octanoyl- loaded acyl carrier protein domain from module mlsa2 of the mycolactone polyketide synthase. |
|
34
|
102
|
5hs7A |
Reduced form of the transcriptional regulator yodb from b. subtilis |
|
91
|
324
|
5hcyA |
Egfr kinase domain mutant "tmlr" with 3-carboxamide azaindole compound 13 |
|
156
|
444
|
4zdlA |
The crystal structure of the t325s mutant of the human holo sepsecs |
|
110
|
271
|
5hmlA |
Crystal structure of t5 d15 protein co-crystallized with metal ions |
|
99
|
347
|
5hlpA |
X-ray crystal structure of gsk3b in complex with brd3937 |
|
194
|
640
|
5he1A |
Human grk2 in complex with gbetagamma subunits and ccg224062 |
|
159
|
460
|
4zf6A |
Cytochrome p450 pentamutant from bm3 with bound peg |
|
107
|
351
|
4zxtA |
Complex of erk2 with catechol |
|
89
|
305
|
5hvjA |
Crystal structure of limk1 d460n mutant in complex with amp-pnp |
|
23
|
104
|
5hdgA |
Crystal structure of heat shock factor 1-dbd |
|
141
|
360
|
5hn7A |
Crystal structure of plasmodium vivax geranylgeranylpyrophosphate synthase complexed with bph-1158 |
|
91
|
323
|
5hibA |
Egfr kinase domain mutant "tmlr" with a pyrazolopyrimidine inhibitor |
|
113
|
358
|
5hn8A |
Crystal structure of plasmodium vivax geranylgeranylpyrophosphate synthase complexed with bph-1182 |
|
49
|
146
|
5hgkA |
Hiv-1 ca n-terminal domain, open conformation |
|
80
|
276
|
5ia5A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with golvatinib (e7050) |
|
79
|
283
|
5hkmA |
Discovery of novel 7-azaindoles as pdk1 inhibitors |
|
171
|
452
|
5b2yA |
Crystal structure of p450bm3 with n-perfluorodecanoyl-l-tryptophan |
|
149
|
399
|
5hdiA |
Structural characterization of cyp144a1, a mycobacterium tuberculosis cytochrome p450 |
|
31
|
101
|
5ilsA |
Autoinhibited etv1 |
|
88
|
283
|
5hg7A |
Egfr (l858r, t790m, v948r) in complex with 1-{(3r,4r)-3-[5-chloro-2-(1-methyl-1h-pyrazol-4-ylamino)-7h-pyrrolo[2,3-d]pyrimidin-4-yloxymethyl]-4-methoxy-pyrrolidin-1-yl}propenone (pf-06459988) |
|
89
|
292
|
4zy6A |
Crystal structure of p21-activated kinase 1 in complex with an inhibitor compound 29 |
|
94
|
361
|
5hvyA |
Cdk8/cycc in complex with compound 20 |
|
62
|
204
|
5ihyA |
The crystal structure of bacillus subtilis semet-ypgq |
|
115
|
347
|
5hd7A |
Dissecting therapeutic resistance to erk inhibition rat mutant sch772984 in complex with (3r)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-n-[3-(pyridin-4-yl)-2h-indazol-5-yl]pyrrolidine-3-carboxamide |
|
91
|
323
|
5hicA |
Egfr kinase domain mutant "tmlr" with a imidazopyridinyl-aminopyrimidine inhibitor |
|
66
|
145
|
5hbiA |
Scapharca dimeric hemoglobin, mutant t72i, co-liganded form |
|
137
|
396
|
4zxvA |
Streptomyces peucetius nitrososynthase dnmz in ligand-free state |
|
24
|
59
|
5b1nA |
Dhp domain structure of envz from escherichia coli |
|
125
|
390
|
5ibgA |
Crystal structure mycobacterium tuberculosis cyp121 in complex with inhibitor fragment 25b |
|
96
|
270
|
5hbhB |
Cdk8-cycc in complex with 5-{5-chloro-4-[1-(2-methoxy-ethyl)-1,8-diaza-spiro[4.5]dec-8-yl]-pyridin-3-yl}-1-methyl-1,3-dihydro-benzo[c]isothiazole 2,2-dioxide |
|
85
|
291
|
5hezA |
Jak2 kinase (jh1 domain) mutant p1057a in complex with tg101209 |
|
66
|
248
|
4yqpA |
Crystal structure of trmd, a m1g37 trna methyltransferase with sam-competitive compounds |
|
238
|
661
|
5h6qA |
Crystal structure of lsd1-corest in complex with peptide 11 |
|
114
|
378
|
5ijxA |
Crystal structure of a c-terminally truncated coccidioides posadasii mitochondrial tyrosyl-trna synthetase |
|
68
|
226
|
5b1bB |
Bovine heart cytochrome c oxidase in the fully reduced state at 1.6 angstrom resolution |
